30-03-2026, 17:00

Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate

Notified -
Globe Newswire30-03-2026, 17:00
28-07-2025, 17:00

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW251, a Novel Glypican 3-Targeted Topoisomerase 1 Inhibitor Antibody-Drug Conjugate

Notified -
Globe Newswire28-07-2025, 17:00
22-07-2024, 17:00

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate
Globe Newswire22-07-2024, 17:00